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Liquid-based cytology represents an opportunity to re-evaluate
endometrial cytology. We evaluated the accuracy of liquid-based
endometrial cytology as compared to biopsy in 670 women
scheduled for histeroscopy because of thickened endometrium
(>4 mm), as evaluated by transvaginal sonography. Endometrial
biopsy detected pathology in 41 (6%) of cases (21 of which
were adenocarcinomas). Cytologic study found pathology in 62
(9%) cases (19 of which were adenocarcinomas). Two hundred
ninety-one biopsies (43%) and 28 (4%) cytologies were inad-
equate. The sensitivity and the specificity were estimated, respec-
tively, at 95% and 98%; the positive and negative predictive
values were estimated, respectively, at 83% and 99%. Cytology
provided sufficient material more often than biopsy (P < 0.01).
We consider endometrial cytology an efficacious diagnostic op-
portunity. It could be usefully applied in association with trans-
vaginal sonography. The combination of these procedures might
reduce more invasive and expensive diagnostic procedures.
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Endometrial adenocarcinoma is the most common malig-
nancy of the female genital tract. A significant increase in
its frequency, both absolute and relative, has been
observed during the last decades. This increase is consid-
ered the consequence of the extended life expectancy of
women, the increase in the incidence of risk factors, and
of the reduction of invasive cervical carcinomas. Nowa-
days, more than 1 in 20 female cancers in Europe are of
the endometrium.1–10
Contrary to cervical carcinoma, no screening programs
have been organized for the early detection of endome-
trial adenocarcinoma. The lack of screening programs
may be related to the precocious presenting symptoms
and to the relative good prognosis of the majority of en-
dometrial adenocarcinomas. Early abnormal uterine bleed-
ing, the commonest presenting symptom for the 95% of
women, allows diagnosis at stage I in 73% of cases.11
Moreover, there has not been an endometrial test compa-
rable to cervicovaginal cytology for diagnostic reliability,
tolerability, and low cost.
Several diagnostic procedures are used for investigating
the endometrium, but there is no common agreement for
the optimum approach in each circumstance (i.e. sympto-
matic vs. asymptomatic; with risk factors vs. without risk
factors).
Endometrial cytology has been hampered in its dissemi-
nation by the difficulty in its interpretation due to the
common presence of excess blood and overlapping cells.
Liquid-based cytology represents an opportunity to re-
examine endometrial cytology. We conducted the current
study to correlate the results of liquid-based endometrial
cytology with the results of endometrial biopsy in a group
of 670 women scheduled for hysteroscopy because of
thick endometrium (>4 mm), as evaluated by transvaginal
sonography (TVS). Our purpose was preliminarily to as-
certain whether the association of the liquid-based endo-
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metrial cytology with TVS may reduce unnecessary more
invasive diagnostic procedures.
Study Population
The patients included in this study were 670 women
scheduled for hysteroscopy because of thickened endome-
trium (>4 mm), as evaluated by TVS in which the ab-
sence of cervical stenosis made the investigation possible.
After providing informed consent, all women were sub-
mitted in sequence to hysteroscopy, endometrial cytology,
and bioptic endometrial sampling.
Their median age was 53 yr (range 24–89). One hun-
dred eight-three (27%) women were referred for uterine
bleeding and 84 (13%) received hormonal therapy.
Methods
Cytological sampling was performed using the Endo-
flower device (RI-MOS, Mirandola, Modena, Italy; http://
www.rimos.com). After the endometrial sampling, the
device tip was immersed in the Cytolyt1 (Cytyc Corpora-
tion, Boxborough, MA) vial where it was vigorously
rotated in order to facilitate cell release. The vial was la-
beled with the appropriate patient information and trans-
ported to the Department of Pathology where the samples
were processed and the diagnoses were made.
The samples were centrifuged and the pellet containing
the cells was transferred into a vial containing Preserv-
Cyt1 (Cytyc Corporation). Blood and mucus were elimi-
nated by means of washing through a succession of
centrifugation and resuspension in N-Acetyl-L-Cisteine
(mucolysis; before the fixation in PreservCyt) and/or ace-
tic acid (hemolysis; after the fixation in PreservCyt). The
vial was inserted into the ThinPrep 2000 automated slide
processor (Cytyc Corporation). The slides were stained
with routine Papanicolau (Pap) stain.
Histologic sampling was performed using the Endoram
device (RI-MOS). Endometrial samples were routinely
fixed in neutral buffered formol, embedded in paraffin,
and stained with hematoxylin–eosin.
Cytological and histological diagnoses were executed
blindly by two cyto-histo-gynecopathologists (AMB,
GLT). In case of discordant diagnosis, both pathologists
reviewed the case together and reached an agreement on
the diagnosis. The slides were considered unsatisfactory
when there were less than five endometrial clusters (endo-
metrial cytology) or severe fragmentation or scarcity of
the endometrial tissue (endometrial biopsy).
The cytological diagnosis was given according to the
criteria that we have previously reported.12 We considered
four categories, normal (grouping proliferative, secretory,
and atrophic endometrium), nonatypical hyperplasia,
atypical hyperplasia, and carcinoma, on the basis of the
architectural and cytological features of the endometrial
clusters considering all anamnestic and clinical informa-
tion (Figs. 1–3). The histological diagnosis was given
according to the World Health Organization (WHO)
criteria.1
Because of the small number of pathologic specimens,
statistical analyses were performed categorizing the cases
as nonpathological and pathological (hyperplasia, atypical
hyperplasia, carcinoma).
The sensitivity was calculated by dividing the true
pathological cases diagnosed by endometrial cytology by
the total number of patients with endometrial pathology
and multiplying by 100; the specificity was calculated by
dividing the number of true negative cases diagnosed by
endometrial cytology by the total number of women who
did not have endometrial disease and multiplying by 100;
the positive predictive value was calculating by dividing
Fig. 1. Proliferative endometrium (A): three-dimensional cylindrical en-
dometrial clusters with preserved polarity formed by isomorphic cells with
scant cytoplasm and regular nuclei; secretory endometrium (B): wide
three-dimensional cylindrical endometrial cluster with preserved polarity
formed by isomorphic cells with wide clear cytoplasm and regular nuclei.
Original magnification: (A) 350; (B) 3200; Hematoxylin–eosin. Fig. 2. Non atypical hyperplasia: wide three-dimensional clusters with
considerable cellular crowding and architectural disorder. Original mag-
nification: 3200; Hematoxylin–eosin.
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the true pathological cases by the total of true positive
cytological specimens and of the false-positive cases and
multiplying by 100; the negative predictive value was cal-
culated by dividing the true negative cases by the total of
true negative and of the false-negative cytological speci-
mens and multiplying by 100. The v2 test was used to
compare the number of unsatisfactory cytological speci-
mens with that of endometrial biopsies. Statistical signifi-
cance was judged as P < 0.04. Data analysis was per-
formed using the Glaz SA 3.03 Version statistical package
(Mc Graw-Hill, 1992, New York, NY).
Results
The evaluation of the biopsies determined that 21 (3%)
women had adenocarcinoma, 4 (<l%) adenomatous atypi-
cal hyperplasia, and 16 (2%) had simple nonatypical
hyperplasia. Endometrial cytology evidenced 19 (3%)
neoplastic cases, 5 (<1%) hyperplastic with atypia cases,
and 38 (6%) hyperplastic without atypia cases (Table I).
Fifteen of 21 (71%) endometrial adenocarcinomas, 2 of
4 (50%) adenomatous atypical hyperplasias, and 5 of
16 (31%) simple nonatypical hyperpasias, as evaluated by
biopsy, occurred in women with abnormal uterine bleed-
ing.
Two hundred ninety-one biopsies (43%) and 28 (4%)
cytologies were inadequate. Of the 291 unsatisfactory en-
dometrial biopsies, 263 (90%) were considered inadequate
by the gynecologists because of the scarcity of the
sampled tissue and since no tissue was sent to the labora-
tory; the remaining 28 (10%) inadequate cases were
judged inadequate by pathologists during histopathologi-
cal evaluation. In 12 cases the cytology was inadequate
and the biopsy was adequate, in 275 cases the biopsy was
inadequate and the cytology was inadequate, and in 16
cases both the cytology and the biopsy were inadequate;
cytohistological correlation was possible in the remaining
367 (55%) cases. In the series of 367 cases in which both
endometrial biopsy and cytology were adequate, endome-
trial cytology recognized 19 neoplastic cases, 5 hyperplas-
tic with atypia cases, and 23 hyperplastic without atypia
cases (Table I). Two endometrial adenocarcinomas and
one atypical hyperplasia were underrated by endometrial
cytology, resulting respectively as atypical hyperplasias
and as nonatypical hyperplasia. Two simple nonatypical
hyperplasias resulted as negative by cytology. Eight cases
were false-positive (nonatypical hyperplasias by cytology,
negative on biopsy) (Table II). When we categorized the
cases studied as nonpathological and pathological, endo-
metrial cytology showed the sensitivity estimated at 95%,
the specificity at 98%, the positive predictive value at
83%, and the negative predictive value at 99%.
Endometrial cytology provided sufficient material for
the diagnosis more often than endometrial biopsy (P <
0.01).
Discussion
Several diagnostic procedures are used to investigate the
endometrium. Endometrial biopsy, particularly under hys-
teroscopic control, is considered the most efficacious one.
However, this procedure may cause anxiety and discom-
fort Consequently, less invasive procedures are commonly
preferred as the first diagnostic approach.
TVS is increasingly being used because it is well toler-
ate. Several studies showed the relationship between
endometrial thickness, as measured by TVS, and endome-
trial pathology. However, the results on the diagnostic ac-
curacy of TVS are conflicting also because of the diffi-
culty to establish a reliable threshold separating normal
Fig. 3. Endometrial adenocarcinoma: small endometrial clusters with ar-
chitectural disorder (B–D) in a phlogistic–necrotic background (A); mac-
ronucleoli and coarsely granular chromatin (D). Original magnification:
(A–D) 3200; Hematoxylin–eosin.
Table I. Histological and Cytological Results (670 Women)
Histology, n Cytology, n
Nonpathological 338 (50)a 580 (87)
Pathological 41 (6)b 62 (9)c
Inadequate 291 (43) 28 (4)
Total 670 (100) 670 (100)
aValues in parentheses indicate percentages.
b21 adenocarcinomas, 4 adenomatous atypical hyperplasias, 16 simple
nonatypical hyperplasias.
c19 adenocarcinomas, 5 atypical hyperplasias, 38 nonatypical hyperpla-
sias.
Table II. Discordant Cases
Cases, n Histology Cytology
8 (2)a Nonpathological Nonatypical hyperplasia
2 (1) Simple nonatypical hyperplasia Nonpathological
2 (1) Adenocarcinomas Atypical hyperplasia
2 (<1) Adenomatous atypical hyperplasia Nonatypical Hyperplasia
aValues is parentheses indicate percentages.
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from abnormally thickened endometrium. There is no
unanimous agreement regarding the endometrial thickness
that have to be considered pathologic.13–18 The endome-
trial thickness physiologically changes in relation to the
age and, in cyclic women, to the endometrial phase. The
administration of hormonal therapy may also influence
the endometrial thickness. Thickened endometrium as
evaluated by TVS may be the consequence of many path-
ological and nonpathological conditions different from
carcinoma or hyperplasia such as endometrial polyps or
cystic endometrium, which is typically induced by tamox-
ifen.13–18 Often, TVS does not provide a definitive diag-
noses particularly due to its high false-positive rate. A
recent meta-analysis of the diagnostic accuracy of endo-
metrial thickness measurements by transvaginal or
transabdominal ultrasound involving 9,031 women with
postmenopausal bleeding reported that using a 5 mm
cut-off level, a positive test raised the probability of carci-
noma from 14.0% to 31.3%, while a negative test reduced
it to 2.5%.19 It is remarkable to note that in our series of
women with thickened endometrium (>4 mm) we
detected pathology in only 41 cases (6%), of which 21
(3%) were adenocarcinomas. The majority of these adeno-
carcinomas (15 cases) occurred in symptomatic patients.
Analogously, in 2005 Tsuda et al. documented that the
prevalence of endometrial disease in asymptomatic and
symptomatic women whit thickened endometrium was
2.3% and 21%.17
Regarding traditional endometrial cytology, despite sev-
eral encouraging results have been reported with sensibil-
ity and specificity reaching 96%,20–24 its diffusion has
been hampered because of technical and diagnostic diffi-
culties.
The diagnostic capacity of endometrial cytology has
improved enough because of the introduction of liquid-
based method. The main characteristics of this method are
the reduction of the obscuring factors, the distribution of
the cells in a thin layer, and the possibility to obtain more
than one slide available for further investigations, i.e.
immunohistochemistry. Moreover, it has recently been
suggested that cell block preparation obtained from liq-
uid-based cytological sampling, when necessary, might
further increase the diagnostic accuracy of thin-layer en-
dometrial cytology.25
Some recent studies emphasised the diagnostic potenti-
ality of endometrial thin-layer cytology: Garcia et al.26 in
2003 reported a very good specificity (96%), a good
(78%) sensitivity, and a low (15%) inadequate rate (lower
than endometrial biopsy calculated at 26%). In the same
year we documented a cytohistologic concordance of 98%
and a low unsatisfactory rate (18%).27 ln 2005, Papaefthi-
miou et al.28 indicated that liquid-based endometrial cy-
tology makes possible a nearly perfect interobserver and
intraobserver agreement.
The low percentage of unsatisfactory specimens (4%),
the high sensitivity (95%), specificity (98%), and positive
(83%) and negative (99%) predictive values found in our
present study support this encouraging results.
The unusual high inadequate rate of endometrial biop-
sies in our collection may be related to the predominance
of peri-postmenopausal women (median age was 53 yr)
and of nonpathological cases (94%); additionally, we
speculate that in our dual sampling protocol the first sam-
pling (in our protocol cytology) might impair the success
of the second sampling (in our protocol biopsy).29
In conclusion we considered endometrial cytology an
efficacious diagnostic opportunity. It could be usefully
applied in association with transvaginal ultrasonography.
The combination of these procedures may improve their
diagnostic accuracy and reduce unnecessary more inva-
sive and more expensive diagnostic procedures.
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